Vitória Régia Pereira Pinheiro

Centro Infantil Boldrini, Conceição de Campinas, São Paulo, Brazil

Are you Vitória Régia Pereira Pinheiro?

Claim your profile

Publications (4)6.88 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT The clinical and molecular findings of 77 neonates (NL) and 380 infant leukemia cases (IL) were selected to distinguish features between NL and IL; somatic gene mutations associated with acute leukemia including FLT3, RAS and PTPN11 were revisited. There were 42 cases of congenital leukemia associated with Down syndrome (DS) and 39 of these cases presented features of acute myeloid leukemia (AML)-M7. Twenty-seven of the DS cases underwent spontaneous remission and were re-classified as a transient myeloproliferative disorder. GATA1 mutations were found in 70% of these cases. In non-DS, frequent abnormalities were MLL rearrangements, mainly MLL-AFF1 in acute lymphoblastic leukemia and MLL-MLLT3 in AML; the FLT3 mutation was not found, while RAS (n=4) and PTPN11 (n=2) mutations were identified and reported for the first time in NL. There was substantial evidence to support that somatic abnormalities occur in utero; thus, congenital leukemia is a good model for understanding leukemogenesis.
    Leukemia and Lymphoma 07/2014; 56(4):1-19. DOI:10.3109/10428194.2014.938327 · 2.89 Impact Factor
  • Source
    Regina Mendonça · Luiz Alcino Gueiros · Kátia Capellaro · Vitória Régia Pereira Pinheiro · Márcio Ajudarte Lopes ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Hydroxyurea (HU) is an antimetabolic agent commonly used in myeloproliferative disorders and hematological diseases as well as in severe psoriasis. Despite of usually be well tolerated, sometimes it can induce immunosuppression and mucocutaneous adverse effects associated with discomfort or pain. Nevertheless, oral mucosal adverse reactions are extremely uncommon and present as ulcers, tongue depapilation and dyschromia. Complete remission of adverse effects is usually observed after withdrawal of the medication. The aim of this paper is to report two patients with oral lesions related to HU treatment. T0 he patients were adequately managed by changing hydroxyurea with imatinib mesilate. Oral lesions are rare complications of long-term hydroxyurea treatment and may be an indication of stopping therapy and substitution with imatinib mesilate.
    Indian journal of dental research: official publication of Indian Society for Dental Research 11/2011; 22(6):869-70. DOI:10.4103/0970-9290.94690
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intensive chemotherapy regimens can result in severe toxicities, particularly those that involve the digestive systems, leading to morbidity and mortality in this group of patients. Acute enterocolitis can be a frequent complication. The authors performed a retrospective review or patients treated at their institution to ascertain the prognostic value of the clinical symptoms and signs of acute enterocolitis, the corresponding abdominal ultrasonographic findings, and the impact of previous chemotherapy. Amongst 1159 patients with cancer treated at the Centro Infantil Boldrini from 2003 to 2007, 188 (16.2%) patients had 1 or more episode of enterocolitis. An intestinal wall thickness of >or=3 mm on ultrasound was considered diagnostic of enterocolitis. There were 231 episodes of enterocolitis with a death rate of 11.7%. Previous therapy with cytarabine and the presence of abdominal distention affected survival. An intestinal wall thickness of >or=10 mm in the ultrasonographic examination was associated with greater mortality. In multivariate analysis, age, gender, tumor type, degree of neutropenia, intestinal wall thickness, and number of intestinal segments were not statistically significant difference. In children and young adults with cancer and enterocolitis, the clinical findings of 4 or more symptoms and presence of abdominal distention were associated with higher risk of death. Use of cytarabine and an intestinal wall thickness of >or=10 mm were associated with a higher death rate.
    Pediatric Hematology and Oncology 09/2010; 27(6):462-70. DOI:10.3109/08880018.2010.489934 · 1.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Denaturing high-performance liquid chromatography (dHPLC) was developed to screen DNA variations by separating heteroduplex and homoduplex DNA fragments by ion-pair reverse-phase liquid chromatography. In this study, we have evaluated the dHPLC screening method and direct sequencing for the detection of GATA1 mutations in peripheral blood and bone marrow aspirates samples from children with Down syndrome (DS). Cases were ascertained consecutively as part of an epidemiological study of DS and hematological disorders in Brazil. A total of 130 samples corresponding to 115 children with DS were analysed using dHPLC and direct sequencing methods to detect mutations in GATA1 exons 2, 3 and 4 gene sequences. The overall detection rate of sequencing and dHPLC screening methods was similar. Twenty mutations were detected in exon 2 and one mutation in exon 3 (c.231_232 dupGT) sequences of acute megakaryoblastic leukemia and transient leukemia samples. Four GATA1 mutations were newly described [c.155C > G; c.156_178 del23 bp; c.29_30 del GG; c.182C > A and c.151A > T,c.153_162 del 10 bp). Out of four, three had single nucleotide change. In conclusion, our results indicate that dHPLC is an efficient and valuable tool for GATA1 mutational analysis.
    Leukemia & lymphoma 06/2009; 50(5):834-40. DOI:10.1080/10428190902829433 · 2.89 Impact Factor